Globus Medical

Globus Medical

Yahoo Finance • 13 hours ago

Natera & Angiex Partner to Evaluate AGX101 Response With Signatera

Natera NTRA recently announced a collaboration with Angiex, Inc. to assess treatment response to AGX101, an investigational nuclear-delivered antibody-drug conjugate (ND-ADC), using its Signatera test. The Phase 1 trial is evaluating AGX10... Full story

Yahoo Finance • 16 hours ago

Should You Add Illumina Stock to Your Portfolio Now?

Illumina Inc. ILMN is well positioned for growth in the coming quarters, driven by strategic execution focused on growing its core sequencing business, expanding multiomics and developing services, data and software capabilities. Ongoing m... Full story

Yahoo Finance • 2 days ago

GMED or ITGR: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Integer (ITGR). But which of these two stocks is more attractive to value investors? We'll need to take a closer look t... Full story

Yahoo Finance • 2 days ago

Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up

Veeva Systems, Inc. VEEV reported adjusted earnings per share (EPS) of $2.35 for the second quarter of fiscal 2027, which increased 18.1% from the year-ago figure of $1.99. Adjusted EPS beat the Zacks Consensus Estimate by 5.9%. GAAP EPS... Full story

Yahoo Finance • 2 days ago

Here's Why Investors Should Retain Molina Healthcare Stock for Now

Molina Healthcare, Inc. MOH is well-positioned for growth, supported by contract wins, strategic acquisitions and solid cash generation capacity. The company operates in three segments: Medicaid, Medicare and Marketplace. Over the past six... Full story

Yahoo Finance • 2 days ago

McKesson to Acquire Precision Medicine Group to Strengthen Services

McKesson Corporation MCK recently announced a definitive agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services. The transaction is expected to strengthen McKesso... Full story

Yahoo Finance • 2 days ago

Is This the Right Time to Hold Medtronic Stock in Your Portfolio?

Medtronic plc MDT is well-poised for growth in the upcoming quarters due to strong momentum in its Cardiovascular businesses, both in the United States and internationally. In Neuroscience, the company is investing across the portfolio to... Full story

Yahoo Finance • 3 days ago

Here's Why You Should Retain IQVIA Stock in Your Portfolio Now

Shares of IQVIA IQV have had an excellent run over the past month. The stock has gained 21.7% compared with the industry and the Zacks S&P 500 Composite's growth of 9.7% and 3.5%, respectively. The company's third-quarter 2026 earnings ar... Full story

Yahoo Finance • 4 days ago

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

McKesson's MCK prospects are being driven by robust growth in specialty distribution, oncology services and biopharma solutions. Earnings are also improving on the back of ongoing operational efficiency and capital discipline despite persi... Full story

Yahoo Finance • 4 days ago

Bausch + Lomb Advances Two First-in-Class Eye Health Therapies

Bausch + Lomb BLCO recently announced that two first-in-class pharmaceutical pipeline candidates will advance to the next stages of clinical development following positive trial results. The programs include a dual-action eye drop for dry... Full story

Yahoo Finance • 4 days ago

The Hospital Bet That Reframes The Intuitive Surgical Stock Story

Photo by 127071 on Pixabay While investors fixate on a slowdown in current procedures, hospitals are accelerating their investment in the company's core platform, revealing a crucial, under-appreciated strength. When a market leader's st... Full story

Yahoo Finance • 4 days ago

Should You Continue to Hold Labcorp Stock in Your Portfolio?

Labcorp Holdings Inc. LH, or Labcorp, is set to benefit from the expansion of its testing capabilities in strategic high-growth areas, including neurology and autoimmune disease. The company's efforts to enhance its partnership with hospit... Full story

Yahoo Finance • 4 days ago

AMN Stock Rallies Nearly 119% YTD: What's Behind the Momentum?

AMN Healthcare Services AMN stock has jumped 118.7% year to date, significantly outperforming its industry's 10.9% gain and the S&P 500's 11.7% growth. The rally reflects improving demand across staffing businesses, stronger execution and... Full story

Yahoo Finance • 5 days ago

Here's Why You Should Retain OPK Stock in Your Portfolio for Now

OPKO Health, Inc. OPK is well-positioned for growth in the coming quarters, supported by the potential of RAYALDEE. Optimism surrounding the stock is driven by RAYALDEE's strong performance, strategic partnerships, BioReference restructuri... Full story

Yahoo Finance • 9 days ago

Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?

Zimmer Biomet ZBH appears well positioned for growth in the coming quarters, supported by healthy orthopedic procedure demand. Also, the company is experiencing strong adoption of Z1, HAMMR and OrthoGrid. Yet, intense competition and an el... Full story

Yahoo Finance • 16 days ago

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly... Full story

Yahoo Finance • last month

STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know

STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans... Full story

Yahoo Finance • last month

Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their fiduciary duties to shareholders.... Full story

Yahoo Finance • last month

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

Globus Medical AUDUBON, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2026 after the market... Full story

Yahoo Finance • 2 months ago

Q2 watchlist: Healthcare stocks with perfect EPS revision scores

[Heart Health Concept] Eoneren/E+ via Getty Images As Q2 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess demand across care delivery, diagnostics, life sciences, pharmaceuticals, medical... Full story